Symvivo

Symvivo

Symvivo is a biotechnology company developing cancer gene therapies for treating cancer.

All edits

Edits on 25 Nov, 2020
Henry Ogolla
Henry Ogolla edited on 25 Nov, 2020
Edits made to:
Timeline (+1 events) (+66 characters)
Timeline

November 24, 2020

Symvivo Corporation announces research collaboration with Janssen.

Edits on 14 Nov, 2020
Daniel Frumkin"added to article to surpass 1000 characters"
Daniel Frumkin edited on 14 Nov, 2020
Edits made to:
Article (+961/-1 characters)
Article

Symvivo is a biotechnology company developing cancer gene therapies for treating cancer that is headquartered in Burnaby, British Columbia and was founded in 2013 by Alexander Graves.

The company is also developing oral DNA vaccines for diseases such as COVID-19, or even genetic diseases. Some of their programs are designed to treat oncological diseases, ischemic heart disease, and other rare diseases. Symvivo is taking part in research and development to prevent COVID-19, and are utilizing their DNA vaccine candidate bacTRL-Spike.

BacTRL-Spike is designed to potentially protect large populations from various emergent pathogens faster than an injectable vaccine. The gene therapy is designed around the limitations of standard gene delivery systems such as accommodating larger and multi-genes, controlling immune responses, or even targeting tissues.

Within oncology, the platform allows for the colonization of solid hypoxic tumors and the establishment of living bio-factories within tumors, which re-programs the tumors physiology. With infectious diseases the platform provides a passage for a bacterial vector containing plasmid DNA.

Edits on 28 Oct, 2020
Golden AI"prospector:29:5145"
Golden AI edited on 28 Oct, 2020
Edits made to:
Infobox (+3 properties)
Infobox
Industry
Research and development
Edits on 25 Mar, 2019
Dawson Sewell
Dawson Sewell edited on 25 Mar, 2019
Edits made to:
Infobox (+8 properties)
Description (+89 characters)
Article (+184 characters)
Further reading (+1 rows) (+4 cells) (+216 characters)
Categories (+1 topics)
Related Topics (+1 topics)
Topic thumbnail

Symvivo

Symvivo is a biotechnology company developing cancer gene therapies for treating cancer.

Article

Symvivo is a biotechnology company developing cancer gene therapies for treating cancer that is headquartered in Burnaby, British Columbia and was founded in 2013 by Alexander Graves.

Further reading

Title
Author
Link
Type

Challenge to Change: Biotech scientist gets the business skills to take his innovations to market

UBC Sauder

Web

Infobox
Location
British Columbia
Industry
Biotechnology
Date incorporated
2013
Categories
Related Topics
Edits on 7 Mar, 2019
Golden AI
Golden AI edited on 7 Mar, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Is a
Company
Edits on 6 Mar, 2019
Umair Shah
Umair Shah approved a suggestion from Golden's AI on 6 Mar, 2019
Edits made to:
Infobox (+2 properties)
Infobox
Location
Burnaby
Umair Shah"Initial topic creation"
Umair Shah created this topic on 6 Mar, 2019
Edits made to:
Topic thumbnail

 Symvivo

Symvivo is a biotechnology company developing cancer gene therapies for treating cancer.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.